American Century Companies Inc Cerus Corp Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$4.41 - $5.69 $590,031 - $761,287
-133,794 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$4.81 - $6.99 $243,294 - $353,561
50,581 Added 60.78%
133,794 $745,000
Q4 2021

Feb 07, 2022
SELL
$5.97 - $7.93 $184,156 - $244,616
-30,847 Reduced 27.04%
83,213 $567,000
Q1 2021

May 14, 2021
BUY
$5.68 - $7.87 $425,182 - $589,116
74,856 Added 190.94%
114,060 $686,000
Q4 2020

Feb 12, 2021
BUY
$5.25 - $8.56 $205,821 - $335,586
39,204 New
39,204 $271,000

Others Institutions Holding CERS

# of Institutions
156
Shares Held
147M
Call Options Held
84.2K
Put Options Held
55.5K
View Full List

About CERUS CORP

CERS Quotes by TradingView
  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $317M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email